Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats.

Nitric oxide (NO), a vasodilator involved in the regulation of pulmonary vascular tone, is synthesized by a family of enzymes, nitric oxide synthases (NOS). To investigate whether adenoviral-mediated overexpression of constitutive endothelial NOS (ceNOS) would attenuate hypoxic pulmonary vasoconstriction, we aerosolized 3 X 10(9) plaque forming units of a recombinant adenovirus containing the ceNOS gene (AdCMVceNOS) into rat lungs. Four days after infection, transgene expression was confirmed using immunoblot techniques. Diffuse ceNOS immunostaining was detected in alveoli and medium-sized and small pulmonary vessels of AdCMVceNOS-transduced lungs. AdCMVceNOS-transduction was associated with an 86% increase in [3H]arginine to [3H]citrulline conversion and a rise in pulmonary cGMP levels from 7 +/- 1 to 59 +/- 9 pmol/mg protein in lungs from AdCMVceNOS versus control rats, (P < 0.05). During acute hypoxia (FIO2 = 0.10) for 25 min, mean pulmonary artery pressure (PAP) increased significantly from 17 +/- 1 to 27 +/- 1 mmHg in rats aerosolized with saline (n = 4) and from 18 +/- 1 to 28 +/- 1 mmHg in rats given an adenoviral vector expressing a nuclear-targeted beta-galactosidase gene (AdCMV beta gal, n = 8). In contrast, in AdCMVceNOS-transduced rats (n = 8) the hypoxia-induced increase in PAP was significantly attenuated (18 +/- 1 to 23 +/- 2 mmHg). Systemic blood pressure was not affected by aerosol gene transfer. Thus, adenoviral-mediated ceNOS gene transfer to rat lungs increases ceNOS expression and activity, and reduces acute hypoxic pulmonary vasoconstriction. Aerosolized recombinant adenovirus overexpressing vasodilatory proteins can act as a selective pulmonary vasodilator and may hold promise as a future therapeutic strategy for pulmonary hypertension.

[1]  A Giaid,et al.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.

[2]  S. M. de la Monte,et al.  Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development. , 1995, The American journal of physiology.

[3]  Jesse D. Roberts,et al.  Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. , 1995, Circulation research.

[4]  R. Johns,et al.  Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. , 1994, The American journal of physiology.

[5]  S. Kostyk,et al.  Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. , 1994, The American journal of physiology.

[6]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[7]  B. Thompson,et al.  Functional and structural changes with hypoxia in pulmonary circulation of spontaneously hypertensive rats. , 1994, Journal of applied physiology.

[8]  P. Shaul,et al.  Acute and Prolonged Hypoxia Attenuate Endothelial Nitric Oxide Production in Rat Pulmonary Arteries by Different Mechanisms , 1993, Journal of cardiovascular pharmacology.

[9]  S. Rimar,et al.  Selective Pulmonary Vasodilation by Inhaled Nitric Oxide Is Due to Hemoglobin Inactivation , 1993, Circulation.

[10]  T. Higenbottam,et al.  Impairment of pulmonary‐artery endothelium‐dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to l‐arginine deficiency , 1993, British Journal of Pharmacology.

[11]  R. Gerard,et al.  Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Hedenstierna,et al.  Inhaled Nitric Oxide Selectively Reverses Human Hypoxic Pulmonary Vasoconstriction without Causing Systemic Vasodilation , 1993, Anesthesiology.

[13]  R. Rossaint,et al.  Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.

[14]  M. Perricaudet,et al.  Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. , 1993, The Journal of clinical investigation.

[15]  O. Griffith,et al.  Mammalian nitric oxide synthases. , 1999, Advances in enzymology and related areas of molecular biology.

[16]  C. Newgard,et al.  Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. , 1992, The Journal of biological chemistry.

[17]  D. Liggitt,et al.  Aerosol gene delivery in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Lehot,et al.  Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. , 1992, Anesthesiology.

[19]  Jesse D. Roberts,et al.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[20]  T. Evans,et al.  Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. , 1992, The American journal of physiology.

[21]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  S. Snyder,et al.  Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Quertermous,et al.  Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. , 1992, The Journal of biological chemistry.

[24]  B. Groves,et al.  An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.

[25]  J. Sixma,et al.  Nitric Oxide Functions as an Inhibitor of Platelet Adhesion Under Flow Conditions , 1992, Circulation.

[26]  S. Soifer,et al.  EDRF inhibition augments pulmonary hypertension in intact newborn lambs. , 1992, The American journal of physiology.

[27]  T. Quertermous,et al.  Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. , 1992, The Journal of biological chemistry.

[28]  T. Higenbottam,et al.  Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension , 1991, The Lancet.

[29]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[30]  J. Wain,et al.  Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction , 1991, Circulation.

[31]  J. Wallwork,et al.  Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. , 1991, The New England journal of medicine.

[32]  T. Hazinski,et al.  Localization and induced expression of fusion genes in the rat lung. , 1991, American journal of respiratory cell and molecular biology.

[33]  A. Newby,et al.  Does nitric oxide inhibit smooth muscle proliferation , 1991 .

[34]  P. Braquet,et al.  Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. , 1991, The Journal of clinical investigation.

[35]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.

[36]  J. Adams,et al.  hypotension: Implications for the involvement of nitric oxide , 2022 .

[37]  R. Johns,et al.  Endothelium-Dependent Relaxation and Cyclic GMP Accumulation in Rabbit Pulmonary Artery Are Selectively Impaired by Moderate Hypoxia , 1989, Circulation research.

[38]  S. Archer,et al.  Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. , 1989, Biochemical and biophysical research communications.

[39]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[40]  P. Vanhoutte.  The endothelium--modulator of vascular smooth-muscle tone. , 1988, The New England journal of medicine.

[41]  S Moncada,et al.  The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. , 1987, Biochemical and biophysical research communications.

[42]  B. J. Sobol,et al.  Gaseous Diffusion from Alveoli to Pulmonary Vessels of Considerable Size , 1963, Circulation research.